HST Global, Inc. (HSTC)

USD 0.59

(0.0%)

Market Cap (In USD)

20.28 Million

Revenue (In USD)

-

Net Income (In USD)

-146.21 Thousand

Avg. Volume

194.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.23-1.15
PE
-
EPS
-
Beta Value
-0.734
ISIN
US40432E2028
CUSIP
40432E202
CIK
797564
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Mike Field
Employee Count
-
Website
https://www.hstglobal.com
Ipo Date
2002-06-24
Details
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life-threatening diseases. HST Global, Inc. is headquartered in Hampton, Virginia.